상세 보기
SUNRAY-02: A Phase 3 Study of Olomorasib and Immunotherapy in Stage II-III KRAS G12C-Mutant NSCLC After Definitive Therapy
- Nadal, E.;
- Chaft, J.;
- Garassino, M.;
- Gray, J.;
- Lee, S-h.;
- 외 14명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0키워드
KRAS-G12C; Olomorasib; NSCLC
- 제목
- SUNRAY-02: A Phase 3 Study of Olomorasib and Immunotherapy in Stage II-III KRAS G12C-Mutant NSCLC After Definitive Therapy
- 저자
- Nadal, E.; Chaft, J.; Garassino, M.; Gray, J.; Lee, S-h.; Lee, J. M.; Mazieres, J.; Neal, J.; Negrao, M. V.; Popat, S.; Senan, S.; Tsuboi, M.; Wu, Y-l.; Lin, B.; Puri, T.; Zhao, X.; Liu, H.; Zhang, Y.; Thomas, M.
- 발행일
- 2025-10
- 유형
- Meeting Abstract
- 권
- 20
- 호
- 10